256 related articles for article (PubMed ID: 22569856)
1. Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control.
Burke JR; Hura GL; Rubin SM
Genes Dev; 2012 Jun; 26(11):1156-66. PubMed ID: 22569856
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding.
Burke JR; Deshong AJ; Pelton JG; Rubin SM
J Biol Chem; 2010 May; 285(21):16286-93. PubMed ID: 20223825
[TBL] [Abstract][Full Text] [Related]
3. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation.
Knudsen ES; Wang JY
Mol Cell Biol; 1997 Oct; 17(10):5771-83. PubMed ID: 9315635
[TBL] [Abstract][Full Text] [Related]
4. Multiple mechanisms for E2F binding inhibition by phosphorylation of the retinoblastoma protein C-terminal domain.
Burke JR; Liban TJ; Restrepo T; Lee HW; Rubin SM
J Mol Biol; 2014 Jan; 426(1):245-55. PubMed ID: 24103329
[TBL] [Abstract][Full Text] [Related]
5. A Strategy for Direct Chemical Activation of the Retinoblastoma Protein.
Pye CR; Bray WM; Brown ER; Burke JR; Lokey RS; Rubin SM
ACS Chem Biol; 2016 May; 11(5):1192-7. PubMed ID: 26845289
[TBL] [Abstract][Full Text] [Related]
6. Deciphering the retinoblastoma protein phosphorylation code.
Rubin SM
Trends Biochem Sci; 2013 Jan; 38(1):12-9. PubMed ID: 23218751
[TBL] [Abstract][Full Text] [Related]
7. Molecular Determinants for the Inactivation of the Retinoblastoma Tumor Suppressor by the Viral Cyclin-dependent Kinase UL97.
Iwahori S; Hakki M; Chou S; Kalejta RF
J Biol Chem; 2015 Aug; 290(32):19666-80. PubMed ID: 26100623
[TBL] [Abstract][Full Text] [Related]
8. v-Jun overrides the mitogen dependence of S-phase entry by deregulating retinoblastoma protein phosphorylation and E2F-pocket protein interactions as a consequence of enhanced cyclin E-cdk2 catalytic activity.
Clark W; Black EJ; MacLaren A; Kruse U; LaThangue N; Vogt PK; Gillespie DA
Mol Cell Biol; 2000 Apr; 20(7):2529-42. PubMed ID: 10713176
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites.
Knudsen ES; Wang JY
J Biol Chem; 1996 Apr; 271(14):8313-20. PubMed ID: 8626527
[TBL] [Abstract][Full Text] [Related]
10. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release.
Rubin SM; Gall AL; Zheng N; Pavletich NP
Cell; 2005 Dec; 123(6):1093-106. PubMed ID: 16360038
[TBL] [Abstract][Full Text] [Related]
11. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
[TBL] [Abstract][Full Text] [Related]
12. Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family.
Liban TJ; Thwaites MJ; Dick FA; Rubin SM
J Mol Biol; 2016 Oct; 428(20):3960-3971. PubMed ID: 27567532
[TBL] [Abstract][Full Text] [Related]
13. Conservation and divergence of C-terminal domain structure in the retinoblastoma protein family.
Liban TJ; Medina EM; Tripathi S; Sengupta S; Henry RW; Buchler NE; Rubin SM
Proc Natl Acad Sci U S A; 2017 May; 114(19):4942-4947. PubMed ID: 28439018
[TBL] [Abstract][Full Text] [Related]
14. A cyclin D1/cyclin-dependent kinase 4 binding site within the C domain of the retinoblastoma protein.
Pan W; Cox S; Hoess RH; Grafström RH
Cancer Res; 2001 Apr; 61(7):2885-91. PubMed ID: 11306463
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of retinoblastoma protein (Rb) phosphorylation at serine sites and an increase in Rb-E2F complex formation by silibinin in androgen-dependent human prostate carcinoma LNCaP cells: role in prostate cancer prevention.
Tyagi A; Agarwal C; Agarwal R
Mol Cancer Ther; 2002 May; 1(7):525-32. PubMed ID: 12479270
[TBL] [Abstract][Full Text] [Related]
16. An overlapping kinase and phosphatase docking site regulates activity of the retinoblastoma protein.
Hirschi A; Cecchini M; Steinhardt RC; Schamber MR; Dick FA; Rubin SM
Nat Struct Mol Biol; 2010 Sep; 17(9):1051-7. PubMed ID: 20694007
[TBL] [Abstract][Full Text] [Related]
17. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro.
Takaki T; Fukasawa K; Suzuki-Takahashi I; Hirai H
Biochem Biophys Res Commun; 2004 Mar; 316(1):252-5. PubMed ID: 15003538
[TBL] [Abstract][Full Text] [Related]
18. S-Phase entry upon ectopic expression of G1 cyclin-dependent kinases in the absence of retinoblastoma protein phosphorylation.
Leng X; Connell-Crowley L; Goodrich D; Harper JW
Curr Biol; 1997 Sep; 7(9):709-12. PubMed ID: 9285720
[TBL] [Abstract][Full Text] [Related]
19. The extreme COOH terminus of the retinoblastoma tumor suppressor protein pRb is required for phosphorylation on Thr-373 and activation of E2F.
Gorges LL; Lents NH; Baldassare JJ
Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1151-60. PubMed ID: 18768921
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the retinoblastoma protein N domain provides insight into tumor suppression, ligand interaction, and holoprotein architecture.
Hassler M; Singh S; Yue WW; Luczynski M; Lakbir R; Sanchez-Sanchez F; Bader T; Pearl LH; Mittnacht S
Mol Cell; 2007 Nov; 28(3):371-85. PubMed ID: 17996702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
